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I t is a m caHirc of o ur in creased scicn tiJic sophistica ti o n in understanding o ne form of e pide rmolys is bullosa (EB) , epidem10lys is bull osa simple x (EBS), that an ed itori al can con centrate on EBS and on th e keratins of the ba sal layer. Background information is g iven for the no n aficion ado to 
appreciate the extent of this progress. 
E rvin Epstein , Jr .'s labora tory, w hich first described a molecul ar 
defect in hum an EBS [1], reports in this iss ue (2] studi es of an 
addi tion al 49 kindreds w ith EBS. Screeni ng fo r mutations by 
single- strand confo rmational po lym o rphism (SSCP) an alysis and 
subseq uent sequ encing, h e fo und less than h alf the number of 
expected mutations in keratin 14. W hether this rep resented sole ly 
the i11 e lficien cy of SSCP analys is, or w hether th ere were m o re 
interesti.n g explanatio ns to consider remains to be de termined. T his 
editoria l pro vides the opportuni ty to consider the gen eral progress 
in understand ing this intriguing and important conditio n , some of 
the features and im pli cations of the keratin mutatio ns in EBS, and 
the importance of th ese o bserva ti ons to genetic coun seling and the 
planning of ratio nal th erapi es for EBS. 
T h e muta tions in KS and K14 have dem o nstrated difFe rent 
re lationships of genotype to ph enotype incl uding recessive and 
dominant inheritan ce, do min ant inheritance w itho ut a dosage effect 
in the do uble mutan t, and null mutants. The mutati ons and their 
consequ en ces are discussed in deta il. Recent rev iews h ave co nsid-
ered tb e gene tic de fec ts in dystrophi c and junctional EB [3 ,4] and in 
EBS (5]. 
LOCATION AND CONS ISTENCY OF KERATIN DEFECTS 
A strong mantra is repeatedl y chan ted about th e genetic defects of 
the keratins: the end portions of th e he lica l portions of the rod-like 
central dom ain and the linker domain between two p o rtions of the 
central rod domain contain highl y conse rved res idues, and disease 
is usually re lated to mu tations in th ese regio ns of the ke ratin 
molecul e, especially in so me highly selected sites (" hot spots") (6]. 
These hot spots usually are res idu es that are identical both be twee n 
keratin types and across lo ng evo lu tion ary lin es; mu tatio ns in these 
re sidues lead to EBS w hen they occur in the ke ratins of the basa l 
layer , K5 and K14. T he Epstein study showed that all ten identifted 
mutation s were w ithin the I A and 2B helices and the L 12 link er 
region , w hich led th e autho rs to con clude that the maj ority of the 
re gions with K1 4 m utations have been identifi ed . New mutatio ns 
fow1 d in the ir studies arc the muta tio n in residue 5 of the he lix 1 A 
re gion , in residu e 12 o f the linke r L12 region , and in residu es 72 
and 83 of the he lix 113 regio n . T hese new mu tations still require 
more de tailed studies in tran sfectio n and he li x initiation and growth 
studies to de termine their precise effects on filament fo rmatio n . 
A general prin cipl e fi·om studies of EBS is that mutations in 
certain location s of the keratins (usually the ends of conserved 
alpha-helical rod domains) are m o re li ke ly to produce the severe 
forms o f E BS (Dowling-Meara disease) ; other mu ta tions in the 
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linker domain o r th e non-he li ca l tail o r head pro du ce e ith er m il der 
gen era lized disease (Koebn er disease) and o thers the m ost-localized 
fonn of EBS (Weber-Cockayn c) . One reservation fo r this gener-
aliza tion is that , althou gh the gen etic data arc precise, the cl inica.l 
assessm en t of the d egr ee of di sease is usually m o re qualitative in 
na ture. An interesting exa mpl e tha t location of th e mutati o n m ay 
be m o re importan t than th e ex ten t of the ch an ge is a pati en t w ith 
Weber-Cockayn e EBS in whose DNA the1·c was a three-nucleotide 
deletion leading to deletion of g lu tarnic acid 375 in the h elix 2B 
region [7]. The del etio n would be expected to locall y interrupt 
keratin dim e,;zation. This deletion is very close to L384P (a leucine 
to proline mutation in residu e 384), w hi ch was associated with a 
Kocbn er form of EBS and produced minim al effects o n ;, 11itro 
functional assays [8] . 
In a study similar to Epste in 's, of 18 unre lated No rth European-
derived kin dreds with Webcr-Cockaync EBS, a single T to G 
tra nsversion mutation in KS resulted in a lie to Ser change in nine 
of th e kindreds, sugges ting that this is a mutation ;J ) hot spot or is 
ba sed o n a founder effect (the presence of a commo n ancestor with 
the di sease in a distan t ge neratio n) [9]. T his mutation is n ear the 
beginning of the K5 rod do m ain an d had been identified in other 
Weber-Cockayn e EBS pa tients [ ·t o·J. Other studies h ave associated 
Weber- Cockayne EBS with muta tio ns in the linker 12 region ("11]. 
The auth o rs suggested that detailed haplotype analysis to dete r-
min e the identi ty of m arkers ve ry closely lin ked to the abnom1a l 
keratin 5 would distingui sh a found er effect fi·om a hot spot. If th ere 
were <1 comm on fo under, there wou ld be a high pro babili ty of 
fi nding a common set of closely linked markers in the regio n of the 
chxom oso me w ith the abnormal KS mutatio n . Eithe r a founder 
effec t or a hot spot migh t be an explana tio n fo r the re lative 
deficien cy of K14 mutations in Epstein 's studies. 
RECESS IVE EPIDERM OLYSIS BULLOSA SIMPLEX 
Alth o ugh appare ntly rare, these patients raise impo rtant cl inical and 
theoretica l qu estions . T his syndrome consists of m oderate to severe 
EB, at tim es assoc iated with extensive o ral lesio ns, alopecia, and 
loss of the nail plates . T he condi tion ca n be sole ly cutaneous o r in 
so me fa mili es associated w ith a form of childh ood progressive 
muscul ar d ystrophy. M o rpho logicall y, there is basa l ce ll clefting 
iden tical to that in dominant EBS. O ne French fa mily studi ed at the 
m o lecul ar level showed that the cl ini ca ll y n o rmal parents (wh o 
were first cousin s) were obligate hcterozygotcs w ith on e abnorm al 
K14 and one no rmal alle le; affected individuals had two abn o rma l 
K14 genes J"l 2] . T h e two afFected children h ad blis te rs on the 
plantar, dorsal, and late ral surfaces of thei r feet, no palmar blisters, 
and blisters o n the thighs and legs afte r h o rseback rid ing. T here was 
an A to C transversion in nu cleoridc 491 changing a g lutamic acid 
to an alanin e in the first a lpha-he lical segm ent of th e K14 rod 
dom ain . T hi s is a hi ghly conserved res idu e in type r keratins and 
type II keratins. It is predi cted that thi s change in amin o acid size, 
shape, an d hydro ph obicity w ill in terfere with K14-K5 heterod imc r 
productio n . Ke ratin fo rmation is considered to begin w ith type I 
and type II hctcropolym crs [1 3] . Al l keratin mutatio ns except for 
this o ne in recessive EBS are dominant negative muta tions. lt is 
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interes ting that under normal clinical conditions the carrie rs arc 
normal , suggesting that the mutatio n by itself is not a do minant 
negative mutation. Further testing of tll.i s mutation in transfection 
studies and isolated filam ents formation wi ll be necessary to 
asce rta in that it is completely l'i:ee of any dominant m utant effects. 
Patients w ith EBS and muscular dystrophy ha ve to be carefull y 
studied for gene lin kage to the known keratin loci and to determine 
whether a keratin , an alte rna te ly sp li ced keratin transcript, o r even 
a ke ratin-associated molecule is altered. 
Sporadic patients w ith severe simplex disease wi ll require de-
ta iled studies, includi ng studies of the ir paren ts, before their 
potentia l for having afFected children can be assessed in preparation 
fo r genetic cou nselin g. Those with recessive disease (and n onca rrier 
spouses) can expect non-affected child ren , w hile those with a 
dominant mutation may require prenata l diagnosis. When sporadic 
patients are studied it wi ll be importan t to recognize that keratins, 
like most other molecul es, conta in am ino ac id changes in some 
portions of the molecule that are benign polymorprusms without 
apparent physiologic effects [2, 12]. The presen ce of recessive EBS 
makes it reasonable to predict that there wi ll be patients w ith EBS 
w ho will be compound he terozygotes, analogous to the fi·equent 
compound heterozygotes for altered tyrosinase fo und in albinism 
[14]. In those predicted compound heterozygotes for keratin 
defects the individual may acquire difFerent mutations in K5 from 
each parent. An even more intriguing possibili ty will be the 
compound heterozygote resu lting fi·om an indi vidu al inhedting an 
abnormal type I keratin from o ne parent and an abnormal type II 
keratin from the oth er parent. 
DOUBLE MUTANTS IN EBS 
A basic principle of genetics is that there are individual patien ts in 
whom the findings can be critical for testing or disproving a 
hypothesis, giving a new insight into the phenotype or the physi-
o logy of a genetic disease. Such a person occurred in a large 
pedigree of EBS in which there was conversion of a conserved 
lysine in position 173 of K5 to an asparagine (K173N [K = lysine 
and N = asparagine in standard single letter code for amino acids]) 
[15]. One patient who was phenotypically identical to others in the 
pedigree was found to be homozygous for the K173N mutation. 
Although there was a doubling of the number of abnormal KS 
m olecules, and there were no normal KS molecules, there was no 
worsening of the clinical phenotype. In some dominant diseases the 
homozygote for the abnormal genes is more severely afFected : 
familia l hypercholesterolenl.ia, C harcot-Marie-Tooth disease, 
achondroplasia (references in [1 5]). T he K173N defect is in domain 
lA near the N-terminal end of a highly conserved helical region. 
T he region is considered critical for the formation of heterodimers. 
T he authors concluded that the KS mutant is fully dominant. 
Studies from Elain e Fuch's laboratory suggest there are other 
poss ibl e considera tions for interpreting the effect of K5 mutations. 
K15 AND K4: SPARE T IRES, SUSPENDERS, BELTS, AND A 
K14 NULL MUTATION 
Redundancy is an essential biologica l strategy. Important functions 
inva ri ab ly have ba ck-up sys tems. Hence, if you rea ll y worry about 
yo ur pants slippin g off you us.: a belt, suspenders, and an e lastic 
waist band. Sometimes you forget about the back-up system. 
Consider the puny spare tire in the trunk of most cars-not 
im press ive but it works w hen needed. What docs thi s have to do 
w ith K4 and K15? D urin g the initia l descrip tions of keratins, K 15 
was fou nd to be a minor component of adu lt epidermis; in ad ul ts, 
cytokeratin 4 was described as an abundant keratin in several 
nonepidcrmal stratified epithe li a such as esophagus, ora l and lin gual 
epithelia. esophag us, vagina , and squamo us ce ll carcinomas in those 
tissues (1 6] . K4 is a typ ica l type II (bas ic) polypeptide, and KlS is a 
typi cal type I (ac idic) po lypeptide in its structura l o rga nizatio n [16] . 
Cytokcratin 15 has 76'Y,, identity in the rod region and 62% overall 
identity with cytokeratin 14. Kl5 is in the same pu lsed gel fi·agment 
with ke ratin 10 113], suggesting it is closely linked to the type I 
acidic kerati n clu ster on chromosome 17ql2-q21. 
THE JOUR.NAL O F INVESTIGATIVE DERMATOLOGY 
Elain e Fuch 's labo ra to1·y has been a leader in demonst rating the 
power of transgeni c models in pred icting important cha racte ri stics 
of human EBS [17] . Mice with de letion mutan ts of K14 showed 
vario us degrees of EBS analogous to the human diseases. T here are 
rare patients w ith severe EB w ho are homozygous for a mutation 
causing premature terminati on of K14; their keratinocytes lacked a 
K14-K5 cytoskelctal network [18 , 19]. ln one patient th.:re was aT 
to A transversio n in nucleotide 612 of K14 leading to a premature 
te rmination codon in the 1 B helical domain [1 8]. T here was no 
detectable message a prote in for a truncated K14. The lack of 
shorten ed protein m ay acco unt for the fact that heterozygotes have 
no clinica l disease and the disease is recess ive. The basal keratino-
cytes were c lear in appearance and did not stain strongly with 
methylene blue, which is a light microscopic clue to th is form of 
EBS. (The keratinocytes lacking K14 had abno rmal mi toch ondrial 
distribution , suggestin g a potential link between recessive EBS and 
the muscle disease discussed above). In a second human K1-+ 
"knock- out," nucleotide 313 and 314 were deleted (consistent 
with a modified mispairing model of deletion) form ing a premature 
stop codon within the n on-helical head region of K14 [19]. In this 
fami ly the carrie rs were normal and there was no reaction with a 
probe for K14 mR.NA. 
Because K5 has a role in main tain ing the level of K14 , tl1e 
presence of KS in these mutants suggested there might be an 
alternative mechanism for maintaining KS. To elucidate th e mech-
anism Fuch's g roup produced mice complete ly deficient in the Kl-+ 
gene (null mutatio n) and studied K15 in deta il [20]. T he mice had 
severe blisterin g, but if they survived 2- 4 weeks and had hair 
growth , their general blistering improved and intraepidermal blis-
ters were l.in1itcd to sites with sparse small hairs such as the ears and 
paws. A sparse filament network was presen t in the basal layers, but 
a normal suprabasal keratin pattern was present. Using a specific 
K15 antibody they found strong labelling in the fi laments of basal 
cells in the vicinity of the hemidesmosomes and desmosomes. 
A lthough the cytoskeletal system was morphologically intact, it was 
not able to prevent mechanical trauma . Kl5 was present at high 
levels in neonatal esophagus and decreased as the animal aged. 
Although previous data had suggested that the K5/14 network is 
necessary for the formation of the K1/Kl 0 network, their data 
suggested to the au thors that the K5/K14 was not necessary. The 
authors state fu rther gen e ablation experiments w ill be required to 
completely establish the roles of K15 . 
The authors hypoth esize that patients with Kl.S mutations might 
have nl.ild EB in the skin and more setious disease in internal 
stratified squam o us epithelia . A direct implication of these studies is 
that it wi ll be necessary to look for mutations in other basal 
keratin s, e.g., K5 and K14, in patients with EB simplex w ho have 
no abnormalities in K4 and K15. 
THE FUTURE 
Gene therapy for ep idermolysis bullosa w ill require precise under-
standing of the phys iology of the disease in addition to its molecular 
pathogenesis. T he therapy of dom in ant negative mutatio ns involves 
special chall enges. Studies such as the ones described in this 
editorial develop the basis for therap ies to alter the synthesis of the 
abnormal ke ratin , engraft stem cells witho ut the abnorm al keratin. 
and other techniqu es . 
Many of the specim ens fo r seve ral of these studi es were made 
possib le because of the activ ities of the EB registry. Before it was 
known that keratin , colla gen VII , and laminin 5 mu tations woul d 
be important for the deta il ed un derstanding of EB, c reative inter-
actions between the resea rch communi ty, the National Institute of 
Arthritis, Musculoskeletal, and Skin Diseases (NIAMS), and 
DEBRA (Dystrophic Epiderm o lys is Bullosa R esea rch Association 
of America) led to an EB registry. The registry all owed increased 
access to patients and in creased cl inica l sophistication in EB, which 
aided all the studi es discussed in this editorial. DEBRA, a voluntary 
associati on begun by parents of patients with severe EB, has been 
successful in in creasing the knowledge and interest of Congress in 
EB research and skin research in general. As we ce lebrate the great 
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accomplishments in understanding El3S and contemplate the new 
questions for the future, let's rem ember the important paradigm of 
how the patients, NIAMS, and in vestigato rs worked together in 
these efforts. 
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